Ponatinib: An update on its drug targets, therapeutic potential and safety
Yue Gao, Yue Ding, Xinran Tai, Chen Zhang, Dong Wang
Topics & Concepts
PonatinibMedicineTyrosine-kinase inhibitorTyrosine kinasePharmacologyDrugToxicityDrug discoveryLeukemiaBosutinibMyeloid leukemiaCancerCancer researchBioinformaticsOncologyDasatinibImatinibInternal medicineBiologyReceptorChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancer